Apr 9, 2019 | Drug & Alcohol Testing News
In the face of Canada’s growing opioid crisis, MaRS has launched an Opioid Data Challenge , in collaboration with Health Canada, with the goal to obtain and test new data sets, sources and methodologies to better understand opioid overdoses and harm in Canada....
Apr 4, 2019 | Drug & Alcohol Testing News
The National Hockey League (NHL) Alumni Association is currently in collaboration with Ontario-based legal cannabis producer Canopy Growth to carry out a research study on the effectiveness of cannabis-based therapies. The goal of the study is to examine the...
Apr 2, 2019 | Drug & Alcohol Testing News
Recent legalization of recreational cannabis in Canada has opened new opportunities for pharmaceutical research. Moreover, public opinion polls indicate that most Canadians trust their doctors in prescribing cannabis-containing pharmeceuticals. A recent study carried...
Mar 28, 2019 | Drug & Alcohol Testing News
Having to pay more for your favourite wine, beer or spirit on April 1st is not an April Fools’ joke. Unless the annual “escalator tax” on beer, wine and spirits is repealed the prices of alcohol will grow in Canada on April 1. The tax is annual, meaning that prices...
Mar 26, 2019 | Drug & Alcohol Testing News
A new study published in the journal Nature describe a method to genetically alter yeast to produce cannabinoids, the active compounds in cannabis, including the psychoactive ingredient tetrahydrocannabinol (THC), as well as the non-psychoactive cannabidiol (CBD)....
Mar 21, 2019 | Drug & Alcohol Testing News
A new treatment is available to Canadians addicted to opioids in the form of an implant which is placed in the upper arm and releases an ongoing low dose of medication for 6 months, with the potential of treatment duration of up to one year. The implant contains...
